Panel discussion

Sartorius Stedim Switzerland AG

Date:April 22, 2024

Panel title

More with less: Expert insights on how process intensification can be used to achieve affordable and sustainable biologics manufacturing

Panel summary

Under the light of changing paradigms in the biopharmaceutical industry more and more focus is given on increasing the productivity, lowering the costs and speeding up the time to clinic. Can a intensified approach towards biopharmaceutical manufacturing shape the future of the whole industry?
Gain crucial insights from different viewpoints by attending the panel discussion with experienced industry leaders out of different functions, positions and modalities in the market.

Speaker information


Gerben Zijlstra, Process Technology Manager, Sartorius Stedim Biotech


Uwe Gottschalk, Operating Partner, Keensight Capital
Eduard Ayuso, Chief Technology Officer, Siegfried Dinamiqs
Georg Blaser, VP Biologics Development Center, Celonic AG
John Manneke, Global Category Manager Drug Substance, Roche AG
Thomas Villiger, Professor of Bioprocess Technology, FHNW

Company profile

Sartorius is a leading international partner of life sciences research and the biopharmaceutical industry. The Bioprocess Solutions division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and economically. The company, with its headquarter in Göttingen, Germany, has a strong global reach with around 60 production and sales sites worldwide.

Further information

Follow us